Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply

被引：0
|
作者：
Cabibbo, G. [1 ,2 ]
Genco, C. [1 ]
Camma, C. [1 ,3 ]
机构：
[1] Univ Palermo, Sez Gastroenterol, DIBIMIS, Palermo, Italy
[2] Univ Palermo, Dipartimento Biopatol & Metodol Biomed, Palermo, Italy
[3] CNR Palermo, IBIM, Palermo, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2012年 / 35卷 / 07期
关键词：
D O I：
10.1111/j.1365-2036.2012.05042.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：862 / 863
页数：2
相关论文
共 50 条
  • [1] Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation
    Saito, M.
    Seo, Y.
    Yano, Y.
    Miki, A.
    Momose, K.
    Hirano, H.
    Yoshida, M.
    Azuma, T.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 861 - 862
  • [2] Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation
    Cabibbo, G.
    Genco, C.
    Di Marco, V.
    Barbara, M.
    Enea, M.
    Parisi, P.
    Brancatelli, G.
    Romano, P.
    Craxi, A.
    Camma, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (02) : 196 - 204
  • [3] Commentary: the impact of compact lipiodolisation following transarterial chemoembolisation for hepatocellular carcinoma - authors' reply
    Kim, D. Y.
    Han, K. -H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (01) : 75 - 75
  • [4] Outcome of patients with hepatocellular carcinoma treated with transarterial chemoembolisation
    Kirstein, M. M.
    Schweitzer, N.
    Ay, N.
    Boeck, C.
    Meyer, B.
    Wacker, F.
    Manns, M. P.
    Vogel, A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 13 - 14
  • [5] CRAFITY score is associated with overall survival in patients with hepatocellular carcinoma treated with transarterial chemoembolisation
    Veelken, Rhea
    Olbrich, Anne
    Schindler, Aaron
    Lieb, Sabine
    Fischer, Janett
    Ebel, Sebastian
    Denecke, Timm
    Berg, Thomas
    van Boemmel, Florian
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S507 - S507
  • [6] Liver transplantation for hepatocellular carcinoma. Influence of transarterial chemoembolisation on recurrence and disease free survival
    Majno, P
    Adam, R
    Ariche, A
    Castaing, D
    Bismuth, H
    [J]. GUT, 1997, 41 : A51 - A51
  • [7] TRANSARTERIAL CHEMOEMBOLISATION IN PATIENTS WITH METASTATIC HEPATOCELLULAR CARCINOMA
    Bettinger, D.
    Spode, R.
    Thimme, R.
    Schultheiss, M.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S460 - S460
  • [8] The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
    Cabrera, R.
    Pannu, D. S.
    Caridi, J.
    Firpi, R. J.
    Soldevila-Pico, C.
    Morelli, G.
    Clark, V.
    Suman, A.
    George, T. J., Jr.
    Nelson, D. R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (02) : 205 - 213
  • [9] Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma-authors' reply
    Menon, Krishna V.
    Hakeem, Abdul R.
    Heaton, Nigel D.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1331 - 1332
  • [10] Transarterial chemoembolisation in hepatocellular carcinoma [Transarterielle perkutane Chemoembolisation beim Leberzellkarzinom]
    Petersen J.
    Henninger B.
    Glodny B.
    Jaschke W.
    [J]. Wiener Medizinische Wochenschrift, 2013, 163 (5-6) : 123 - 127
12345